Interestingly, our previous study revealed that PRPS2 expression involved in sertoli-cell only syndrome (SCOS) and inhibits the apoptosis of sertoli cells via the p53/Bcl-2/caspases signaling pathway 9. The gene discussed is TP53; the disease is small cell osteogenic sarcoma.